Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-22-005598

Options or other derivatives

  • Chief Medical Officer acquired 101,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2022-01-14 Grant or award · Restricted Stock Units +33,750 33,750 D
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2022-01-14 Grant or award · Stock Option (right to buy) +67,500 67,500 D
Loading xslF345X03/tm223806-3_4seq1.xml…